Publications of C. Behl

Klostermann, A.; Lutz, B.; Gertler, F.; Behl, C.: The orthologous human and murine semaphorin 6A-1 proteins (SEMA 6 A-1/Sema 6 A-1) binf to the enabled/vasodilator-stimulated phosphoprotein-like protein (EVL) via a novel carboxyl-terminal zyxin-like domain. Journal of Biological Chemistry 275, pp. 39647 - 39653 (2000)

Lezoualc'h, F.; Engert, S.; Berning, B.; Behl, C.: Corticotropin-releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic ß-precursor protein and with the suppression of nuclear factor κB. Molecular Endocrinology 14, pp. 147 - 159 (2000)

Moosmann, B.; Behl, C.: Cytoprotective antioxidant function of tyrosine and tryptophan residues in transmembrane proteins. European Journal of Biochemistry 267, pp. 5687 - 5692 (2000)

Post, A.; Crochemore, C.; Uhr, M.; Holsboer, F.; Behl, C.: Differential induction of NF-κB activity and neural cell death by antidepressants in vitro. European Journal of Neuroscience 12, pp. 4331 - 4337 (2000)

Wolozin, B.; Behl, C.: Mechanisms of neurodegenerative disorders: Part 1: protein aggregates. Archives of Neurology 57, pp. 793 - 796 (2000)

Wolozin, B.; Behl, C.: Mechanisms of neurodegenerative disorders: Part 2: control of cell death. Archives of Neurology 57, pp. 801 - 804 (2000)

Behl, C.: Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches. Progress in Neurobiology 57, pp. 301 - 323 (1999)

Behl, C.: Vitamin E and other antioxidants in neuroprotection. International Journal of Vitamin and Nutrition Research 69, pp. 213 - 219 (1999)

Behl, C.; Holsboer, F.: The female sex hormone estrogen as neuroprotectant. Trends in Pharmacological Sciences 20, pp. 441 - 444 (1999)

Heck, S.; Lezoualc'h, F.; Engert, S.; Behl, C.: Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of NF-kB. Journal of Biological Chemistry 274, pp. 9828 - 9835 (1999)

Moosmann, B.; Behl, C.: The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proceedings of the National Academy of Sciences USA 96, pp. 8867 - 8872 (1999)

Vedder, H.; Anthes, N.; Stumm, G.; Würz, C.; Behl, C.; Krieg, J.-C.: Estrogen hormones reduce lipid peroxidation in cells and tissues of the central nervous system. Journal of Neurochemistry 72, pp. 2531 - 2538 (1999)

Behl, C.: Effects of glucocorticoids on oxidative stress-induced hippocampal cell death: implications for the pathogenesis of Alzheimer's disease. Experimental Gerontology 33, pp. 689 - 696 (1998)

Behl, C.: Transkriptionsfaktor NF-κB und oxidativer Nervenzelltod. Neuroforum 3, pp. 229 - 236 (1998)

Behl, C.; Holsboer, F.: Oxidativer Stress in der Pathogenese von Morbus Alzheimer und antioxidative Neuroprotektion. Fortschritte der Neurologie/Psychiatrie 66, pp. 113 - 121 (1998)

Behl, C.; Lezoualc'h, F.: Estrogens with an intact phenolic group prevent death of neuronal cells following glutathione depletion. Restorative Neurology and Neuroscience 12, pp. 127 - 134 (1998)

Lezoualc'h, F.; Behl, C.: Transcription factor NF-κB: friend or foe of neurons? Molecular Psychiatry 3, pp. 15 - 20 (1998)

Lezoualc'h, F.; Sagara, Y.; Holsboer, F.; Behl, C.: High constitutive NF-κB activity mediates resistance to oxidative stress in neuronal cells. Journal of Neuroscience 18, pp. 3224 - 3232 (1998)

Lezoualc'h, F.; Sparapani, M.; Behl, C.: N-acetyl-serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF-κB. Journal of Pineal Research 24, pp. 168 - 178 (1998)

Post, A.; Holsboer, F.; Behl, C.: Induction of NF-κB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-κB and neuroprotection by antioxidants. Journal of Neuroscience 18, pp. 8236 - 8246 (1998)